[1]
Houbaida, Y. et al. 2025. Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS. Mediterranean Journal of Hematology and Infectious Diseases. 17, 1 (Feb. 2025), e2025026. DOI:https://doi.org/10.4084/MJHID.2025.026.